GPCR · NASDAQ
Structure Therapeutics (GPCR) Stock Price & Fundamentals
Structure Therapeutics (GPCR) closed at $246.24 on Oct 9, 2026, down 0.44% from the previous close of $247.32.
Share price, past year
1Y +34.03%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $246.24 |
| Sep 30, 2026 | $250.76 |
| Aug 31, 2026 | $226.66 |
| Jul 31, 2026 | $222.99 |
| Jun 30, 2026 | $222.80 |
| May 29, 2026 | $228.62 |
| Apr 30, 2026 | $221.19 |
| Mar 31, 2026 | $216.89 |
| Feb 27, 2026 | $216.97 |
| Jan 30, 2026 | $195.77 |
| Dec 31, 2025 | $190.56 |
| Nov 28, 2025 | $181.16 |
| Oct 31, 2025 | $176.74 |
Key statistics
- Market cap
- $52.61B
- EPS (TTM)
- −$1.01
- Net income (TTM)
- −$214.84M
- Shares outstanding
- 213.7M
- 52-week range
- $175.30 – $250.76
Structure Therapeutics's market cap is $52.61B, based on a share price of $246.24 and 213.7M shares outstanding as of Jun 30, 2026.
Financials
Structure Therapeutics's SEC filings don't report revenue in the standard form Laurel reads, so its revenue history isn't shown yet.
Structure Therapeutics reported a net loss of $141.20M in fiscal 2025.
Company profile
- Name
- Structure Therapeutics Inc.
- Ticker
- GPCR
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 601 Gateway Blvd Suite 900, South San Francisco, CA 94080
- Incorporated in
- E9
- Fiscal year ends
- December
- SEC CIK
- 0001888886
Recent SEC filings
- Sep 8, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jun 18, 2026
- May 7, 2026
- May 7, 2026
- Apr 15, 2026
- Mar 16, 2026
Frequently asked questions
What is Structure Therapeutics's stock price?
Structure Therapeutics (GPCR) closed at $246.24 on Oct 9, 2026, down 0.44% from the previous close of $247.32.
What is Structure Therapeutics's market cap?
Structure Therapeutics's market cap is $52.61B, based on a share price of $246.24 and 213.7M shares outstanding as of Jun 30, 2026.
Does Structure Therapeutics pay a dividend?
Structure Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Structure Therapeutics Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures